Detection Of Beijing Genotype Of MDR M. Tuberculosis By Targeting Rv2820 Gene And Their Association With Drug Resistance Mutations In KatG, RpoB And EmbB | 50580
Journal of Infectious Diseases & Therapy
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Beijing genotype of Mycobacterium tuberculosis has attracted special attention due to its association with multi drug resistance and
rapid transmission. The present study was undertaken to investigate the prevalence of Beijing genotype of M. tuberculosis and
their association with drug resistance and clinical characteristics of TB patients. A total of 381 clinical isolates were cultured from
more than 4000 TB patientsâ sputum samples from 2008 to 2014, of which the genetic profile was determined by using multiplex-PCR
and Spoligotyping methods and the drug susceptibility testing to first-line anti-TB drugs was performed by using proportion method
and MGIT960. Detection of mutations at rpoB codons (516, 526 and 531), katG codon 315 and embB codon 306 in Beijing and non-
Beijing-strains were determined by MAS-PCR and DNA-sequencing. We also characterized a collection of M. tuberculosis isolates
to see if Beijing strains had a higher rate of mutations in katG315, rpoB-RRDR region and embB306 gene. Multidrug-resistance was
observed to be significantly associated with Beijing strains (p=0.03) and a strong correlation between Beijing strains and specific
resistance mutations in katG315, rpoB531 and embB306 gene segments was also found (p=<0.0001, <0.0001 & 0.0014 respectively).
These findings will help to understand the transmission and drug resistance related genetic characteristics of the Beijing/W genotype
of M. tuberculosis and may provide a scientific basis for the development of new TB diagnostic tool for effective management and
control of TB in countries with higher prevalence of Beijing strains.
Anamika Gupta has completed her PhD from Banaras Hindu University, India and Postdoctoral studies from National AIDS Research Institute, India. Currently, she is working with Boston University School of Medicine as a Visiting Researcher. She has published 13 papers in peer reviewed journals and 5 manuscripts are in process. She has also published 3 chapters in the books of international repute.